CVS Health and Walgreens Finally Breaking Out

Posted on by Noah Kiedrowski

CVS Health (CVS) and Walgreens Boots Alliance (WBA) have broken out recently due to a pair of better than expected quarters and speculation of being taken private, respectively. These stocks have been beaten down for years with CVS and Walgreens plummeting by 54% ($113 to $52) and 49% ($97 to $49), respectively, from their multi-year highs. Over $110 billion in combined market capitalization had been erased from these two companies. As of late, CVS has broken out to the mid $70s, and Walgreens has demonstrated strength into the low $60s, well of their respective lows.

The single-payer narrative being pushed by presidential frontrunners and the Amazon threat via its acquisitions of PillPack/Whole Foods potentially displacing traditional pharmacies weighed heavily on these companies. Additionally, drug pricing pressures are eroding margins and limiting margin expansion over time along with the secular decline in the physical storefront retail space is hindering foot traffic and same-store sales growth. The culmination of all the aforementioned factors resulted in CVS Health and Walgreens Boots Alliance being pressured in many different directions. With threats coming from all angles, these two pharmaceutical supply chain heavyweights are not only surviving but competing and reviving their dominance in the marketplace.

CVS’ Recent Rise

CVS is fresh off back-to-back quarters that have beat analysts’ expectations while generating large amounts of free cash flow, paying down debt and returning value to shareholders. To further boost long-term growth prospects, restore growth, and fend off potential competition, CVS acquired Aetna. This creates the first through-in-through healthcare company, combining CVS's pharmacies and PBM platform with Aetna's insurance business. The new CVS combines its existing pharmacy benefits manager (PBM) and retail pharmacies with the second-largest diversified healthcare company. This is a bold and hefty price tag to pay yet necessary to compete in the increasingly competitive healthcare space, changing marketplace conditions and political backdrop with drug pricing pressures. CVS is making a defensive yet necessary acquisition before it can go back on the offensive moving into the future. The acquisition will provide CVS with more scale to negotiate for better prices for the prescription drugs it sells through its PBM business. Continue reading "CVS Health and Walgreens Finally Breaking Out" →

Bitcoin Drops To Six-Month Low

Posted on by The INO.com Team

Hello traders everywhere. Bitcoin's price has briefly dropped below $7,000, hitting an intra-day low of $6,785, its lowest level since May 17, 2019, when it hit a low of $6,178. This move lower has wiped out the +30% single-day gain on Oct. 25, 2019, that had pulled Bitcoin out of a long-term downtrend or bear market. Bitcoin triggered a new red weekly Trade Triangle at the beginning of the week, signaling entry into a long-term downtrend and indicating that a move lower could be on the horizon. That was the start of what would be a -15% loss for the week.

What's ahead for Bitcoin? With this move lower Bitcoin is now trading below its 50-day MA, the MACD has turned lower, and the RSI is no below the 30 level which would lead you to believe that a move lower in on the horizon. Our key level to watch will be $9,586.50. A move above that level will trigger a green weekly Trade Triangle indicating a move to a sidelines position.

Stocks rose Friday for the first time in four days after President Trump said China and the U.S. were nearing a trade deal. Trump told Fox News both sides were very close to reaching a trade agreement, nothing: "We have a very good chance to make the deal." His comments came after Chinese President Xi Jinping said Friday that Beijing wants to work for a trade deal with the U.S. but is not afraid to “fight back.” Xi also told a visiting U.S. business delegation that China holds a ‘positive attitude’ toward the trade talks. Continue reading "Bitcoin Drops To Six-Month Low" →

Target (TGT) and The Monthly Trade Triangles

Posted on by The INO.com Team

There's no doubt that Target (TGT) has been one of the hottest stocks of the year capping off the year with a move to a record high of $125.32, gaining over +12% on the day. Target has gained +67% on the year. The question is, have you been in on this historic run? As a MarketClub member, did you use the monthly Trade Triangles to enter the Target trade?

Today I'm going to use Target (TGT) as an example of how you can use the monthly Trade Triangles to capture long-term profits while making minimum trades and letting your money do the work for you.

There were a total of seven trades dating back to 2/23/2012, 5 winning trades and two losing trades resulting in a profit of +$74.43 a share.


Click on the image to enlarge

First, let's review the rules for trading the Monthly Trade Triangles.

Monthly Trade Triangles determine the overall long-term trend and the entry points and exit points. Continue reading "Target (TGT) and The Monthly Trade Triangles" →

Platinum Could Rocket To $1912

Posted on by Aibek Burabayev

Last time I updated the platinum chart in March was when "Palladium Pushed Platinum To A Record Low" within the ratio mostly due to the strength of palladium. Platinum has hovered around $900 for three years now as it was lost and forgotten after the “execration” of diesel engines. This "fallen angel" had been shaping a sideways consolidation this past spring, and I had thought it could repeat 2018’s drop following the same structure. The targets were set at the $640 and $401 on the downside, and the invalidation point was assigned to $1034.

Let's see below how you voted for the future of platinum.

Platinum

Most of you picked the $1034 option, which implied the breakout of the consolidation in the upside direction towards the invalidation area. This was the closest call as the majority voted for a bullish move, which, indeed, had happened as platinum couldn't break below the consolidation valley of $788 and bounced up to reach the $1000 level this past September. That price hasn't been seen since February 2018. Again, this was your amazingly accurate prediction, not only for that period but also for a longer-term outlook as I spotted it in the big chart below. Continue reading "Platinum Could Rocket To $1912" →

VIX Warns Of Imminent Market Correction

Posted on by Chris Vermeulen

The VIX is warning that a market peak may be setting up in the global markets and that investors should be cautious of the extremely low price in the VIX. These extremely low prices in the VIX are typically followed by some type of increased volatility in the markets.

The US Federal Reserve continues to push an easy money policy and has recently begun acquiring more dept allowing a deeper move towards a Quantitative Easing stance. This move, along with investor confidence in the US markets, has prompted early warning signs that the market has reached near extreme levels/peaks.

VIX Value Drops Before Monthly Experation

When the VIX falls to levels below 12~13, this typically very low level is usually associated with an extreme peak in price. Throughout history, after the VIX has collapsed to these types of low price levels, the markets have a tendency to revert/correct in ranges that are typically in excess of 3.5% to 5.5%. In some cases, these corrections have been as large as 11% to 18% or more.

VIX
Continue reading "VIX Warns Of Imminent Market Correction" →